Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Davis

Showing results (31-40 of 205) with videos related to

Pageof 21
Sort By:
Pediatric Research|March 28, 2025
Pregnancy lifestyle interventions and child health: lessons learned from the GeliS trialGregory P Goldstein, Elizabeth Yen, Jonathan M Davis
Therapeutic Innovation & Regulatory Science|April 16, 2019
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug DevelopmentElizabeth Yen, Jonathan M Davis, Christopher-Paul Milne
Journal of Perinatology : Official Journal of the California Perinatal Association|February 8, 2022
Challenges and opportunities for improving access to approved neonatal drugs and devicesTamorah Lewis, Kelly C Wade, Jonathan M Davis
Pediatric Research|November 3, 2021
Correction: The impact of antenatal cannabis use on the neonate: time for open engagement?Rachana Singh, DeWayne M Pursley, Jonathan M Davis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2008
Treatment of ostial lesions using the Szabo technique: a case seriesRobert J Applegate, Jonathan M Davis, Joshua C Leonard
Clinical Therapeutics|June 8, 2025
Prenatal Opioid Exposure: Have We Lost an Opportunity to Improve the Outcomes of Mothers and Their Infants?Jonathan M Davis, Lauren M Jansson, Hendree E Jones
Frontiers in Genetics|February 27, 2023
A review of the genomics of neonatal abstinence syndromeElizabeth Yen, Nathan Gaddis, Lauren Jantzie, et al.
JAMA|April 14, 2022
Implementation of a Standardized Clinical Definition of Opioid Withdrawal in the Neonate: Challenges and OpportunitiesShahla M Jilani, Hendrée E Jones, Jonathan M Davis
JAMA Pediatrics|June 13, 2017
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug TherapyMark A Turner, Ronald J Portman, Jonathan M Davis
Pediatric Research|April 2, 2022
Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?Stephen J McWilliam, Mark A Turner, Jonathan M Davis
Pageof 21

Showing results (31-40 of 205) with videos related to

Sort By:
Pageof 21
Pediatric Research|March 28, 2025
Pregnancy lifestyle interventions and child health: lessons learned from the GeliS trialGregory P Goldstein, Elizabeth Yen, Jonathan M Davis
Therapeutic Innovation & Regulatory Science|April 16, 2019
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug DevelopmentElizabeth Yen, Jonathan M Davis, Christopher-Paul Milne
Journal of Perinatology : Official Journal of the California Perinatal Association|February 8, 2022
Challenges and opportunities for improving access to approved neonatal drugs and devicesTamorah Lewis, Kelly C Wade, Jonathan M Davis
Pediatric Research|November 3, 2021
Correction: The impact of antenatal cannabis use on the neonate: time for open engagement?Rachana Singh, DeWayne M Pursley, Jonathan M Davis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2008
Treatment of ostial lesions using the Szabo technique: a case seriesRobert J Applegate, Jonathan M Davis, Joshua C Leonard
Clinical Therapeutics|June 8, 2025
Prenatal Opioid Exposure: Have We Lost an Opportunity to Improve the Outcomes of Mothers and Their Infants?Jonathan M Davis, Lauren M Jansson, Hendree E Jones
Frontiers in Genetics|February 27, 2023
A review of the genomics of neonatal abstinence syndromeElizabeth Yen, Nathan Gaddis, Lauren Jantzie, et al.
JAMA|April 14, 2022
Implementation of a Standardized Clinical Definition of Opioid Withdrawal in the Neonate: Challenges and OpportunitiesShahla M Jilani, Hendrée E Jones, Jonathan M Davis
JAMA Pediatrics|June 13, 2017
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug TherapyMark A Turner, Ronald J Portman, Jonathan M Davis
Pediatric Research|April 2, 2022
Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?Stephen J McWilliam, Mark A Turner, Jonathan M Davis
Pageof 21